Mercer Global Advisors
ICCC icon

Mercer Global Advisors’s ImmuCell ICCC Stock Holding History

Mercer Global Advisors’s Portfolio ICCC Stock Details ICCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-11,202
Closed -$106K – 1781
2021
Q2 		$106K Hold
11,202
– – ﹤0.01% 1617
2021
Q1 		$108K Hold
11,202
– – ﹤0.01% 1549
2020
Q4 		$67K Hold
11,202
– – ﹤0.01% 1311
2020
Q3 		$61K Buy
+11,202
New +$62.1K ﹤0.01% 1197

Other funds holding ICCC

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MFW
Meristem Family Wealth Minnetonka, Minnesota $925M AUM 14.15% 1-Year Est. Return
OMC
Overbrook Management Corp New York $663M AUM 35.04% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
SFS
Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Mercer Global Advisors's ICCC Position: Q3 2021 in Review

Mercer Global Advisors sold out of ImmuCell (ICCC) in Q3 2021, closing a stake of 11,202 shares — an estimated $106K sold.

Mercer Global Advisors first reported a position in ICCC in Q3 2020 and held it in 4 quarters. The position peaked at $108K in Q1 2021. 28 funds tracked by Wall St. Rank hold ICCC as of Q3 2021.

  • Mercer Global Advisors reported no remaining ImmuCell position as of Q3 2021 after selling out during the quarter.
  • Mercer Global Advisors sold 11,202 ImmuCell shares in Q3 2021, an estimated $106K.
  • Mercer Global Advisors first reported a position in ImmuCell in Q3 2020 and held it in 4 quarters.
  • Mercer Global Advisors's ImmuCell position peaked at $108K in Q1 2021.
  • 28 funds tracked by Wall St. Rank held ImmuCell as of Q3 2021.

Based on Mercer Global Advisors's 13F filing for Q3 2021, filed 10 Nov 2021.